Insmed (INSM) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $108.31 +3.71%
Financial Fact:
Interest expense: -769K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest expense: -769K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.51), $0.02 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $201 at Guggenheim
- Netflix gains after Ackman endorsement and AI feature launch
- Citadel sees year-end stock rally as Wall Street’s biggest buyers return
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
